InvestorsHub Logo

DewDiligence

01/08/18 7:12 PM

#15905 RE: DewDiligence #15496

DewDiligence

01/24/18 9:19 AM

#15994 RE: DewDiligence #15496

ABT 4Q17 sales by business segment:

Medical devices 36% (+10% YoY)
Nutrition 24% ( +2% YoY)
Diagnostics 25% ( +7% YoY)
Pharmaceuticals† 15% (+14% YoY)

65% of overall sales were ex-US.

†Ex-US branded generics.